Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer

NCT02070952 is registered in ClinicalTrials.gov with Riverside Community Hospital, California as lead sponsor.

NCT NCT02070952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02070952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer
Lead sponsor
Riverside Community Hospital, California
Phase
Not applicable
Overall status
Unknown status
Start date
July 31, 2013
Completion date
July 31, 2018
Enrollment
167 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer